JPRN-UMIN000046026已完成未知
TWICE-Follow up study - TWICE-Follow up study
Sanzai Hospital0 个研究点目标入组 82 人开始时间: 2021年11月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who have been denied data use by opt-out (2) Patients who are judged to be inappropriate by the investigator or researcher
研究者
相似试验
进行中（未招募）
不适用
Prospective non-interventional double study about gender specific differences in the treatment of colorectal cancer - Version: Treatment with Irinotecan containing regimens LIV PharmaC18C19C20Malignant neoplasm of rectosigmoid junctionMalignant neoplasm of colonMalignant neoplasm of rectumDRKS00009342IV Pharma GmbH80
进行中（未招募）
不适用
Observational (non-interventional), follow-up trial assessing long-term local tolerability and efficacy (recurrence rate) of resiquimod gel in patients treated for actinic keratosis.MedDRA version: 14.1Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersActinic KeratosisEUCTR2012-003589-42-DESpirig Pharma AG80
已完成
不适用
Study to Explore the Long-Term Consequences in Vaccinated Individual.CTRI/2021/08/035660il407
已完成
不适用
A Study to Explore the Long-Term Consequences in Covid-19 Recovered Individual.CTRI/2021/08/035758Adichunchanagiri University624
进行中（未招募）
不适用
A study to verify the statusof the patients who participated to the RHODOS trial in the pasteber’s Hereditary Optic NeuropathyMedDRA version: 13.1Level: LLTClassification code 10062951Term: Leber's hereditary optic atrophy neuropathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-001034-42-DESanthera Pharmaceuticals (Switzerland) Limited85